ALB and sarcopenia: On univariate analysis, independent survival predictors were the presence of pre-SBRT sarcopenia, SMI loss, biological effective dose, ECOG, presence of extrahepatic metastasis, neutrophil-to-lymphocyte ratio (NLR), albumin-bilirubin score, tumor size, multiple tumors, and macrovascular invasion.